Researchers analysed thousands of laboratory-made plasmids and discovered that nearly half of them had defects, raising questions of experimental reproducibility.
Aggregated News
The bill is sponsored by the California-based personal genome services provider 23andMe. It follows actions last year by the California Department of Public Health (CDPH), which sent letters to 12 businesses offering direct-to-consumer (DTC) genetic testing, including 23andMe, ordering them to stop selling tests in the state until they demonstrated compliance with state and federal regulations. The relevant federal law is the Clinical Laboratory Improvement Amendments (CLIA), whose requirements are implemented and enforced by the states. The CDPH letters stated that the companies must have a California license and a CLIA certificate to operate, may not provide tests without a physician order, and...